July/August 2001 :: Vol 31 No 7/8
Clinical and prevention
1. Abe, T., Mizuta, T., Hatta, T., Miyano-Kurosaki, N., Fujiwara, M., Takai, K., Shigeta, S., Yokota, T., and Takaku, H. (2001) Antisense therapy of influenza. European Journal of Pharmaceutical Sciences. vol. 13(1) 61-9
2. Aiba, H., Mochizuki, M., Kimura, M., and Hojo, H. (2001) Predictive value of serum interleukin-6 level in influenza virus-associated encephalopathy. Neurology. vol. 57(2) 295-9
3. Ando, Y., Iwasaki, T., Terao, K., Nishimura, H., and Tamura, S. (2001) Conjunctivitis following accidental exposure to influenza B virus/Shangdong/07/97. Journal of Infection. vol. 42(3) 223-4
4. [Anon] (2001) Delayed influenza vaccine availability for 2001-02 season and supplemental recommendations of the Advisory Committee on Immunization Practices (Reprinted from MMWR, vol 50, pg 581-585, 2001). Jama-Journal of the American Medical Association. vol. 286(5) 528-29
5. [Anon] (2001) Flow of flu vaccine will be a little slow this year, but faster than last year's. Clinical Infectious Diseases. vol. 33(4) p. I-I
6. Anonymous (2001) Delayed influenza vaccine availability for 2001-02 season and supplemental recommendations of the Advisory Committee on Immunization Practices. MMWR - Morbidity & Mortality Weekly Report . vol. 50(27) 582-5
7. Anonymous (2001) [Despite ongoing epidemic. Preventive influenza vaccination is still of value]. [German]. MMW Fortschritte der Medizin. vol. 143(11) p. 53
8. Anonymous (2000) [Early Tamiflu therapy of influenza can reduce disease time by half]. [German]. Krankenpflege Journal. vol. 38(9-10) 348-9
9. Anonymous (2001) From the Centers for Disease Control and Prevention. Update: influenza activity--United States and worldwide, 2000-01 season, and composition of the 2001-02 influenza vaccine. JAMA. vol. 286(1) 36-8
10. Baldo, V., Menegon, T., Bonello, C., Floreani, A., Trivello, R., and Mariutto Collaborative Grp (2001) Comparison of three different influenza vaccines in institutionalised elderly. Vaccine. vol. 19(25-26) 3472-5
11. Berry, B. B., Ehlert, D. A., Battiola, R. J., and Sedmak, G. (2001) Influenza vaccination is safe and immunogenic when administered to hospitalized patients. Vaccine. vol. 19(25-26) 3493-98
12. Brydak, L. B., Fracka, B., Machala, M., and Szkudlarek, D. (2001) Antibody response to influenza vaccine in children with bronchopulmonary dysplasia. Infection. vol. 29(3) 181-2
13. Burnett, D., Widemark, E., and Yeargin, P. (2000) Should a sick NP be sent home? Advance for Nurse Practitioners. vol. 8(7) p. 27
14. Buxton, J. A., Skowronski, D. M., Ng, H., Marion, S. A., Li, Y., King, A., and Hockin, J. (2001) Influenza revaccination of elderly travelers: Antibody response to single influenza vaccination and revaccination at 12 weeks. Journal of Infectious Diseases. vol. 184(2) 188-91
15. Carroll, N. V., Delafuente, J. C., Mcclure, K. L., Weakley, D. F., Khan, Z. M., and Cox, F. M. (2001) Economic burden of influenza-like illness in long-term-care facilities. American Journal of Health-System Pharmacy. vol. 58(12) 1133-8
16. Colombo, C., Argiolas, L., La Vecchia, C., Negri, E., Meloni, G., and Meloni, T. (2001) Influenza vaccine in healthy preschool children. Revue D'Epidemiologie et de Sante Publique . vol. 49(2) 157-62
17. Coonrod, J. D. (2001) Influenza - Will new diagnostic tests and antiviral drugs make a difference? Chest. vol. 119(6) 1630-2
18. Cross, J. and Wedekind, C. A. (2001) Advances in pharmacology. New treatments for influenza: neuraminidase inhibitors. Medicine & Health, Rhode Island . vol. 84(6) 209-11
19. Davis, L. E. and Kornfeld, M. (2001) Experimental influenza B viral myositis. Journal of the Neurological Sciences. vol. 187(1-2) 61-7
20. Dayan, G. H., Nguyen, V. H., Debbag, R., Gomez, R., and Wood, S. C. (2001) Cost-effectiveness of influenza vaccination in high-risk children in Argentina. Vaccine. vol. 19(30) 4204-13
21. Dennis, C. (2001) The bugs of war. Nature. vol. 411(6835) 232-35
22. Dillon, M. J. (2001) Henoch-Schonlein purpura with antiphospholipid antibodies following an influenza vaccination: Commentary. Pediatric Nephrology . vol. 16(5) 460-62
23. Dolan, B. (2000) Assessing flu patients. Nursing Times. vol. 96(12) 23-9
24. Drusano, G. L., Preston, S. L., Smee, D., Bush, K., Bailey, K., and Sidwell, R. W. (2001) Pharmacodynamic evaluation of RWJ-270201, a novel neuraminidase inhibitor, in a lethal murine model of influenza predicts efficacy for once-daily dosing. Antimicrobial Agents and Chemotherapy. vol. 45(7) 2115-8
25. Edwards, K. M. and Decker, M. D. (2001) Combination vaccines. [Review] [64 refs]. Infectious Disease Clinics of North America . vol. 15(1) 209-30
26. Fitzner, K. A., Shortridge, K. F., McGhee, S. M., and Hedley, A. J. (2001) Cost-effectiveness study on influenza prevention in Hong Kong. Health Policy . vol. 56(3) 215-34
27. Fleming, D. M. (2001) Managing influenza: amantadine, rimantadine and beyond. [Review] [62 refs]. International Journal of Clinical Practice. vol. 55(3) 189-95
28. Fukuda, K., Thompson, W. W., and Cox, N. (2001) Vaccinating Japanese schoolchildren against influenza. New England Journal of Medicine. vol. 344(25) 1947-8
29. Gemmill, I. and Heart and Stroke Foundation of Canada (2000) Influenza immunization for high risk populations. Canadian Journal of Cardiology. vol. 16(9) 1075-6
30. Grabenstein, J. D. (2001) Nasal influenza vaccine: a bridge to full-service vaccine delivery by pharmacists. Journal of the American Pharmaceutical Association. vol. 41(3) p. 473
31. Grabenstein, J. D., Guess, H. A., Hartzema, A. G., Koch, G. G., and Konrad, T. R. (2001) Effect of vaccination by community pharmacists among adult prescription recipients. Medical Care. vol. 39(4) 340-8
32. Grunewald, T., Waizmann, M., Schulze, M. H., and Ruf, B. R. (2001) The role of modern antiviral therapy in prophylaxis and therapy of influenza virus infection. [German]. Medizinische Welt . vol. 52(5) 121-125
33. Hak, E., Moons, K. G., Verheij, T. J., and Hoes, A. W. (2001) Clinical signs and symptoms predicting influenza infection. Archives of Internal Medicine. vol. 161(10) 1351-2
34. Hall, G. H. (2001) Antiflu, or antideath vaccination?. Lancet. vol. 357(9274) p. 2141
35. Hara, Y., Ikematsu, H., Nabeshima, A., Hagiwara, A., Nobutomo, K., and Kashiwagi, S. (2001) [Reduction of medical resources utilization by influenza vaccination for hospitalized elderly patients]. [Japanese]. Kansenshogaku Zasshi - Journal of the Japanese Association for Infectious Diseases. vol. 75(3) 181-5
36. Hay, A., Gust, I., Hampson, A., Tashiro, M., and Cdc (2001) Update: Influenza activity - United States and worldwide, 2000-01 season, and composition of the 2001-02 influenza vaccine (Reprinted from MMWR, vol 50, pg 466-470, 2001). Jama-Journal of the American Medical Association. vol. 286(1) 36-8
37. Hayden, F. G., Jennings, L., Robson, R., Schiff, G., Jackson, H., Rana, B., McClelland, G., Ipe, D., Roberts, N., and Ward, P. (2000) Oral oseltamivir in human experimental influenza B infection. Antiviral Therapy. vol. 5(3) 205-13
38. Hirose, Y., Shibuya, H., Okazaki, E., Aono, K., Tokunaga, A., Taguchi, S., Haraguchi, M., and Honda, H. (2001) Toxic shock-like syndrome with flu-like prodrome: a possible role of 'enhancing tissue focus' for streptococcal toxic shock. Journal of Infection. vol. 42(3) 195-200
39. Inouye, S. and Kramer, M. H. (2001) Vaccinating Japanese schoolchildren against influenza. New England Journal of Medicine. vol. 344(25) 1946, discussion 1947-8
40. Inouye, S. and Kramer, M. H. (2001) Vaccinating Japanese schoolchildren against influenza. New England Journal of Medicine. vol. 344(25) 1947-8
41. Ito, T., Shibata, K., Watanabe, A., and Akabane, J. (2001) Neuroleptic malignant syndrome following withdrawal of amantadine in a patient with influenza A encephalopathy. European Journal of Pediatrics . vol. 160(6) p. 401
42. Ivanova, V. T., Burtseva, E. I., Oskerko, T. A., Kolobukhina, L. V., and Slepushkin, A. N. (2000) [Variability and prevalence characteristics of Influenza A virus (H1N1). Voprosy Virusologii. vol. 45(5) 18-22
43. Kaufman, Z., Cohen-Manheim, I., and Green, M. S. (2000) Compliance with influenza vaccination in Israel in two successive winters, 1998/1999 and 1999/2000. Israel Medical Association Journal: IMAJ. vol. 2(10) 742-5
44. Kawaguchi, M., Kokubu, F., Kuga, H., Tomita, T., Matsukura, S., Suzaki, H., Huang, S. K., and Adachi, M. (2001) Influenza virus A stimulates expression of eotaxin by nasal epithelial cells. Clinical and Experimental Allergy. vol. 31(6) 873-80
45. Kikawada, M., Oyama, T., Ogawa, K., Fukutomi, A., Arai, H., Katsunuma, H., Iwamoto, T., and Takasaki, M. (2001) [Noninvasive positive-pressure ventilation in an elderly woman with acute respiratory failure caused by influenza a virus pneumonia]. [Japanese]. Nippon Ronen Igakkai Zasshi - Japanese Journal of Geriatrics . vol. 38(3) 409-13
46. Kimball, P., Verbeke, S., and Tolman, D. (2001) Influenza vaccination among heart transplant recipients. Transplantation Proceedings. vol. 33(1-2) 1785-6
47. Kiseleva, I. V., Naumenko, Z. S., Kuznetsova, S. A., Klimov, A. I., and Aleksandrova, G. I. (2000) [Criteria of primary screening of attenuated strains for live vaccine against Influenza A]. [Russian]. Voprosy Virusologii. vol. 45(5) 22-6
48. Kistner, O., Barrett, N., Mundt, W., Reiter, M., Schober-Bendixen, S., and Eder (2001) [Development of a novel influenza vaccine derived from a continuous cell line]. [German]. Altex-Alternativen Zu Tierexperimenten. vol. 18(1) 50-4
49. Kobashi, Y., Ohba, H., Yoneyama, H., Okimoto, N., and Soejima, R. (2001) [Comparison of community-acquired pneumonia in relation to influenza A and RS virus infections]. [Japanese]. Kansenshogaku Zasshi - Journal of the Japanese Association for Infectious Diseases. vol. 75(1) 42-7
50. Luce, B. R., Zangwill, K. M., Palmer, C. S., Mendelman, P. M., Yan, L. H., Wolff, M. C., Cho, I. S., Marcy, S. M., Iacuzio, D., and Belshe, R. B. (2001) Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children. Pediatrics. vol. 108(2) p. E24
51. Mauldin, S. C., Hornback, W. J., and Munroe, J. E. (2001) Synthesis of pentenoic acid analogs as potential anti-influenza agents. Journal of the Chemical Society-Perkin Transactions 1. (13) 1554-58
52. McCall, S., Henry, J. M., Reid, A. H., and Taubenberger, J. K. (2001) Influenza RNA not detected in archival brain tissues from acute encephalitis lethargica cases or in postencephalitic Parkinson cases. Journal of Neuropathology and Experimental Neurology. vol. 60(7) 696-704
53. McClellan, K. and Perry, C. M. (2001) Erratum: Oseltamivir: A review of its use in influenza (Drugs (2001) 61:2 (263-283)). Drugs . vol. 61(6) 263-83
54. McEhaney, J. E., Gravenstein, S., Upshaw, C. M., Hooton, J. W., Krause, P., Drinka, P., and Bleackley, R. C. (2001) Granzyme B: a marker of risk for influenza in institutionalized older adults. Vaccine. vol. 19(27) 3744-51
55. Mignogna, M. D., Muzio, L. L., and Ruocco, E. (2000) Pemphigus induction by influenza vaccination. International Journal of Dermatology. vol. 39(10) p. 800
56. Mihara, M., Utsugisawa, K., Konno, S., and Tohgi, H. (2001) Isolated lesions limited to the bilateral substantia nigra on MRI associated with influenza A infection. European Neurology . vol. 45(4) 290-1
57. Molrine, D. C. and Hibberd, P. L. (2001) Vaccines for transplant recipients. Infectious Disease Clinics of North America . vol. 15(1) 273-305
58. Monto, A. S., Hornbuckle, K., and Ohmit, S. E. (2001) Influenza vaccine effectiveness among elderly nursing home residents: A Cohort Study. American Journal of Epidemiology. vol. 154(2) 155-60
59. Munoz, F. M. and Englund, J. A. (2001) Vaccines in pregnancy. [Review] [85 refs]. Infectious Disease Clinics of North America . vol. 15(1) 253-71
60. Murakami, M., Towatari, T., Ohuchi, M., Shiota, M., Akao, M., Okumura, Y., Parry, M. A., and Kido, H. (2001) Mini-plasmin found in the epithelial cells of bronchioles triggers infection by broad-spectrum influenza A viruses and Sendai virus. European Journal of Biochemistry . vol. 268(10) 2847-55
61. Neuzil, K. M., Griffin, M. R., and Schaffner, W. (2001) Influenza vaccine: issues and opportunities. [Review] [84 refs]. Infectious Disease Clinics of North America . vol. 15(1) 123-41
62. Nicholson, K. G., Colegate, A. E., Podda, A., Stephenson, I., Wood, J., Ypma, E., and Zambon, M. C. (2001) Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza. Lancet. vol. 357(9272) 1937-43
63. Nishioka de, A., Shenson, D., Cassarino, L., DiMartino, D., Bolen, J., Good, B., Alderman, M., and Marantz, P. (2001) In response to the February 2001 article entitled 'Improving access to mammography through community-based influenza clinics: A quasi-experimental study'. What exactly is a quasi-experimental study? (multiple letters) [1]. American Journal of Preventive Medicine . vol. 21(2) p. 152
64. Oh, J. (1999) KePRO priming for adult vaccination campaign. Pennsylvania Medicine. vol. 102(11) p. 6
65. Oliveira, E. C., Marik, P. E., and Colice, G. (2001) Influenza pneumonia - A descriptive study. Chest. vol. 119(6) 1717-23
66. Onitsuka, H., Imamura, T., Miyamoto, N., Shibata, Y., Kashiwagi, T., Ayabe, T., Kawagoe, J., Matsuda, J., Ishikawa, T., Unoki, T., Takenaga, M., Fukunaga, T., Nakagawa, S., Koiwaya, Y., and Eto, T. (2001) Clinical manifestations of influenza a myocarditis during the influenza epidemic of winter 1998-1999. Journal of Cardiology . vol. 37(6) 315-23
67. Pean, Y. (2001) Bacterial Epidemiology, aspects of bacterial superinfection during acute bronchitis in adults without previous respiratory tract disease. [French]. Medecine et Maladies Infectieuses . vol. 31(4) 206-10
68. Poole, P. J., Chacko, E., Wood-Baker, R. W., and Cates, C. J. (2000) Influenza vaccine for patients with chronic obstructive pulmonary disease. [Review] [52 refs]. Cochrane Database of Systematic Reviews [computer file] . (4) p. CD002733
69. Poulios, N. S., Song, J., Ackermann, S. P., Armstrong, E. P., Khan, Z. M., Perry, A. S., and Perri, L. R. (2001) Zanamivir vs Oseltamivir: Which drug is more cost-effective?. Formulary . vol. 36(5) 383-384+387
70. Pregliasco, F., Mensi, C., Serpilli, W., Speccher, L., Masella, P., and Belloni, A. (2001) Immunogenicity and safety of three commercial influenza vaccines in institutionalized elderly. Aging (Milano) . vol. 13(1) 38-43
71. Rawlinson, W. D. (2001) Antiviral agents for influenza, hepatitis C and herpesvirus, enterovirus and rhinovirus infections. Medical Journal of Australia. vol. 175(2) 112-16
72. Rea, E. and Upshur, R. (2001) Semmelweis revisited: the ethics of infection prevention among health care workers. [letter; comment]. CMAJ. vol. 164(10) 1447-8
73. Reese, S., Owen, P., Bender, B., Potts, G., Davis, B., Leff, M., Adams, M., Breukelman, F., Bullo, I., Hoecherl, S., Martin, L., Reyes-Salvail, F., Aydelotte, J., Steiner, B., Stemnock, L., Davila, J., Hunt, C., Sparks, T., Bates, B., Maines, D., Weinstein, A., Brooks, D., Mcgee, H., Salem, N., Johnson, D., Jackson-Thompson, J., Feigley, P., Andelt, L., Dejan, E., Powers, L., Boeselager, G., Honey, W., Baker, C., Gizlice, Z., Shireley, L., Pullen, P., Baker, K., Pickle, K., Mann, L., Cintron, Y., Hesser, J., Wu, M., Gildmaster, M., Ridings, D., Condon, K., Marti, K., Roe, C., Carswell, K., Wynkoopsimmons, K., King, F., Pearson, K., Futa, M., Poel, A., and Cdc (2001) Influenza and pneumococcal vaccination levels among persons aged >= 65 years - United States, 1999 (Reprinted from MMWR, vol 50, pg 532-537, 2001). Jama-Journal of the American Medical Association. vol. 286(4) 413-14
74. Reichert, T. A., Sugaya, N., Fedson, D. S., Glezen, W. P., Simonsen, L., and Tashiro, M. (2001) Vaccinating Japanese schoolchildren against influenza. Reply. New England Journal of Medicine. vol. 344(25) 889-96
75. Reina, J. (2001) [Is rapid and specific virological detection of influenza really necessary?]. [Spanish]. Enfermedades Infecciosas y Microbiologia Clinica. vol. 19(2) 47-8
76. Sakai, S., Ochiai, H., Mantani, N., Kogure, T., Shibahara, N., and Terasawa, K. (2001) Administration of isoferulic acid improved the survival rate of lethal influenza virus pneumonia in mice. Mediators of Inflammation. vol. 10(2) 93-6
77. Schmidtke, M., Schnittler, U., Jahn, B., Dahse, H. M., and Stelzner, A. (2001) A rapid assay for evaluation of antiviral activity against coxsackie virus B3, influenza virus A, and herpes simplex virus type 1. Journal of Virological Methods. vol. 95(1-2) 133-43
78. Schultze, D., Thomas, Y., and Wunderli, W. (2001) Evaluation of an optical immunoassay for the rapid detection of influenza A and B viral antigens. European Journal of Clinical Microbiology & Infectious Diseases . vol. 20(4) 280-83
79. Shepardson, S. (2001) Influenza vaccine delays in 2000: the Rhode Island response. Medicine & Health, Rhode Island. vol. 84(4) 140-1
80. Sidwell, R. W., Smee, D. F., Bailey, K. W., and Burger, R. A. (2001) Primary immune system effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 in influenza virus-infected mice. International Immunopharmacology. vol. 1(6) 1211-8
81. Slepushkin, V. A., Staber, P. D., Wang, G., McCray, P. B. Jr, and Davidson, B. L. (2001) Infection of human airway epithelia with H1N1, H2N2, and H3N2 influenza A virus strains. Molecular Therapy: the Journal of the American Society of Gene Therapy . vol. 3(3) 395-402
82. Smith, D. W. (2001) Using neuraminidase inhibitors against influenza. Medicine Today . vol. 2(7) 63-8
83. Stephenson, I. and Nicholson, K. G. (2001) Influenza: vaccination and treatment. European Respiratory Journal. vol. 17(6) 1282-93
84. Stuck, B. (2001) Should children be vaccinated against flu?. [German]. Tagliche Praxis . vol. 42(2) p. 272
85. Sukhinin, V. P., Zarubaev, V. V., Platonov, V. G., Kovalenko, A. L., and Ershov, F. I. (2000) [Protective effect of cycloferon in experimental influenza]. [Russian]. Voprosy Virusologii. vol. 45(5) 26-30
86. Takahashi, H., Fujii, H., Shindo, N., and Taniguchi, K. (2001) Evaluation of the Japanese school health surveillance system for influenza. Japanese Journal of Infectious Diseases. vol. 54(1) 27-30
87. Tree, J. A., Richardson, C., Fooks, A. R., Clegg, J. C., and Looby, D. (2001) Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains. Vaccine. vol. 19(25-26) 3444-50
88. Trzonkowski, P. (2001) [The effect of influenza vaccine on the immune system in elderly persons]. [Polish]. Polski Merkuriusz Lekarski. vol. 10(56) 75-9
89. van't Veen, A. J. (2001) Vaccines without thiomersal: Why so necessary, why so long coming?. Drugs . vol. 61(5) 565-72
90. Wareing, M. D. and Tannock, G. A. (2001) Live attenuated vaccines against influenza; an historical review. Vaccine. vol. 19(25-26) 3320-30
91. Watanabe, T. and Onda, H. (2001) Henoch-Schonlein purpura with antiphospholipid antibodies following an influenza vaccination. Pediatric Nephrology . vol. 16(5) 458-9
92. Weitzman, J. (2001) Stopping the flu. Trends in Molecular Medicine. vol. 7(4) p. 150
93. Yamazaki, T., Suzuki, T., and Yamamoto, K. (2001) Vaccinating Japanese schoolchildren against influenza. New England Journal of Medicine. vol. 344(25) 1947, discussion 1947-8
94. Yamazaki, T., Suzuki, T., and Yamamoto, K. (2001) Vaccinating Japanese schoolchildren against influenza. New England Journal of Medicine. vol. 344(25) p. 1947
95. Zambon, M. C. (2001) The pathogenesis of influenza in humans. Reviews in Medical Virology. vol. 11(4) 227-41
Epidemiology
96. Anonymous (2001) Birds in Hong Kong destroyed to stem avian influenza outbreak. Clinical Infectious Diseases . vol. 33(2) p. ii
97. Anonymous (2001) Influenza B virus outbreak on a cruise ship--Northern Europe, 2000. MMWR - Morbidity & Mortality Weekly Report. vol. 50(8) 137-40
98. Anonymous (2001) Update: influenza activity--United States and worldwide, 2000-01 season, and composition of the 2001-02 influenza vaccine. MMWR - Morbidity & Mortality Weekly Report. vol. 50(22) 466-79
99. Banzhoff, A., Kaniok, W., and Muszer, A. (2001) Effectiveness of an influenza vaccine used in Poland in the 1998-1999 influenza season. Immunological Investigations. vol. 30(2) 103-13
100. Cullinane, A., Weld, J., Osborne, M., Nelly, M., Mcbride, C., and Walsh, C. (2001) Field studies on equine influenza vaccination regimes in thoroughbred foals and yearlings. [see comments]. Veterinary Journal . vol. 161(2) 174-85
101. Cyranoski, D. (2001) Outbreak of chicken flu rattles hong kong. Nature. vol. 412(6844) p. 261
102. Freymuth, F., Vabret, A., Gouarin, S., Petitjean, J., and Campet, M. (2001) [Epidemiology of respiratory virus infections]. [Review] [16 refs] [French]. Allergie et Immunologie. vol. 33(2) 66-9
103. Gregory, V., Lim, W., Cameron, K., Bennett, M., Marozin, S., Klimov, A., and Hall (2001) Infection of a child in Hong Kong by an influenza A H3N2 virus closely related to viruses circulating in European pigs. Journal of General Virology. vol. 82(Pt 6) 1397-406
104. Gross, Z. (2001) Planning for an influenza pandemic. Pharmaceutical Journal . vol. 266(7146) p. 629
105. Hudson, R. J. (2001) Disease surveillance versus viral surveillance [1]. Clinical Infectious Diseases . vol. 33(2) 265-66
106. Lai, A. C. K., Chambers, T. M., Holland, R. E., Morley, P. S., Haines, D. M., Townsend, H. G. G., and Barrandeguy, M. (2001) Diverged evolution of recent equine-2 influenza (H3N8) viruses in the Western Hemisphere. Archives of Virology. vol. 146(6) 1063-74
107. Lambers, J. H. and Cornelissen, P. M. (2000) [Discussion on avian influenza in chicks]. [Dutch]. Tijdschrift voor Diergeneeskunde. vol. 125(23) p. 737
108. Munk-Jorgensen, P. and Ewald, H. (2001) Epidemiology in neurobiological research: exemplified by the influenza-schizophrenia theory. [Review] [19 refs]. British Journal of Psychiatry - Supplement. vol. 40 s30-20
109. Narukawa, M., Minezaki, K. K., Okubo, M., and Kario, K. (2001) Impact of an influenza pandemic on the mortality of congestive heart failure in older Japanese: The 1998 Japanese influenza pandemic [8]. Journal of the American Geriatrics Society . vol. 49(5) 689-90
110. Newton, J. R. (2001) Equine influenza vaccine performance: Still learning lessons from the field. Veterinary Journal . vol. 161(2) 107-9
111. Roger, P. M., Eberhartd, P., Sola, L., Cottalorda, C., Caramella, A., Tamisier, R., Alluni, V., Fournier, J. P., Bertrand, F., and Dellamonica, P. (2001) Lessons from a specific unit for epidemic influenza virus infection. [French]. Revue de Medecine Interne . vol. 22(5) 433-9
112. Sominina, A. A., Monaenkov, A. O., Smorodintseva, E. A., Litvinova, O. M., Iukhnova, L. G., Rodionova, V. B., Lobova, T. G., and Deeva, E. G. (2001) [Analysis of etiology of influenza-like morbidity and monitoring influenza epidemic of 1998-1999 by laboratory diagnosis methods]. [Russian]. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk. vol. (3) 8-12
113. Takahashi, M. and Tango, T. (2001) [A proposal for a new definition of excess mortality associated with influenza-epidemics and its estimation]. [Japanese]. Nippon Koshu Eisei Zasshi - Japanese Journal of Public Health . vol. 48(5) 402-8
Immunology
114. Asanuma, H., Hirokawa, K., Uchiyama, M., Suzuki, Y., Aizawa, C., Kurata, T., Sata, T., and Tamura, S. (2001) Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine. Vaccine. vol. 19(28-29) 3981-9
115. Baumgarth, N. (2000) A two-phase model of B-cell activation. [Review] [58 refs]. Immunological Reviews. vol. 176 171-180
116. Belz, G. T., Xie, W., and Doherty, P. C. (2001) Diversity of epitope and cytokine profiles for primary and secondary influenza a virus-specific CD8+ T cell responses. Journal of Immunology. vol. 166(7) 4627-33
117. Benton, K. A., Misplon, J. A., Lo, C. Y., Brutkiewicz, R. R., Prasad, S. A., and Epstein, S. L. (2001) Heterosubtypic immunity to influenza a virus in mice lacking IgA, all Ig, NKT cells, or [gamma][delta] T cells. Journal of Immunology . vol. 166(12) 7437-45
118. Brokstad, K. A., Cox, R. J., Eriksson, J. C., Olofsson, J., Jonsson, R., and Davidsson, A. (2001) High prevalence of influenza specific antibody secreting cells in nasal mucosa. Scandinavian Journal of Immunology. vol. 54(1-2) 243-7
119. Chen, D. X., Periwal, S. B., Larrivee, K., Zuleger, C., Erickson, C. A., Endres, R. L., and Payne, L. G. (2001) Serum and mucosal immune responses to an inactivated influenza virus vaccine induced by epidermal powder immunization. Journal of Virology. vol. 75(17) 7956-65
120. Chen, W., Norbury, C. C., Cho, Y., Yewdell, J. W., and Bennink, J. R. (2001) Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens. Journal of Experimental Medicine. vol. 193(11) 1319-26
121. Faulkner, L., Buchan, G., Lockhart, E., Slobbe, L., Wilson, M., and Baird, M. (2001) IL-2 linked to a peptide from influenza hemagglutinin enhances T cell activation by affecting the antigen-presentation function of bone marrow-derived dendritic cells. International Immunology. vol. 13(6) 713-21
122. Gerhard, W. (2001) The role of the antibody response in influenza virus infection. [Review] [111 refs]. Current Topics in Microbiology & Immunology . vol. 260 171-90
123. Haan, L., Verweij, W. R., Holtrop, M., Brands, R., van Scharrenburg, G. J., Palache, A. M., Agsteribbe, E., and Wilschut, J. (2001) Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity. Vaccine. vol. 19(20-22) 2898-907
124. Huber, V. C., Lynch, J. M., Bucher, D. J., Le, J., and Metzger, D. W. (2001) Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections. Journal of Immunology . vol. 166(12) 7381-8
125. Kambayashi, T., Assarsson, E., Chambers, B. J., and Ljunggren, H. G. (2001) Expression of the DX5 antigen on CB8<sup>+</sup> T cells is associated with activation and subsequent cell death or memory during influenza virus infection. European Journal of Immunology . vol. 31(5) 1523-30
126. Kronin, V., Fitzmaurice, C. J., Caminschi, I., Shortman, K., Jackson, D. C., and Brown, L. E. (2001) Differential effect of CD8+ and CD8- dendritic cells in the stimulation of secondary CD4+ T cells. International Immunology. vol. 13(4) 465-73
127. Liang, B., Hyland, L., and Hou, S. (2001) Nasal-associated lymphoid tissue is a site of long-term virus-specific antibody production following respiratory virus infection of mice. Journal of Virology. vol. 75(11) 5416-20
128. Lunn, D. P., Hussey, S., Sebing, R., Rushlow, K. E., Radecki, S. V., Whitaker-Dowling, P., Youngner, J. S., Chambers, T. M., Holland, R. E. Jr, and Horohov, D. W. (2001) Safety, efficacy, and immunogenicity of a modified-live equine influenza virus vaccine in ponies after induction of exercise-induced immunosuppression. Journal of the American Veterinary Medical Association. vol. 218(6) 900-6
129. Moriabadi, N. F., Niewiesk, S., Kruse, N., Jung, S., Weissbrich, B., ter Meulen V, Toyka, K. V., and Rieckmann, P. (2001) Influenza vaccination in MS: absence of T-cell response against white matter proteins. Neurology. vol. 56(7) 938-43
130. Nichols, J. E., Niles, J. A., and Roberts, N. J. (2001) Human lymphocyte apoptosis after exposure to influenza A virus. Journal of Virology. vol. 75(13) 5921-9
131. Oh, S., Belz, G. T., and Eichelberger, M. C. (2001) Viral neuraminidase treatment of dendritic cells enhances antigen-specific CD8(+) T cell proliferation, but does not account for the CD4(+) T cell independence of the CD8(+) T cell response during influenza virus infection. Virology. vol. 286(2) 403-11
132. Okuda, K., Ihata, A., Watabe, S., Okada, E., Yamakawa, T., Hamajima, K., Yang, J., Ishii, N., Nakazawa, M., Okuda, K., Ohnari, K., Nakajima, K., and Xin, K. Q. (2001) Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene. Vaccine. vol. 19(27) 6053-60
133. Prasad, S. A., Norbury, C. C., Chen, W., Bennink, J. R., and Yewdell, J. W. (2001) Cutting edge: recombinant adenoviruses induce CD8 T cell responses to. Journal of Immunology. vol. 166(8) 4809-12
134. Sasaki, S., Amara, R. R., Oran, A. E., Smith, J. M., and Robinson, H. L. (2001) Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases. [see comments]. Nature Biotechnology . vol. 19(6) 543-7
135. Sjolander, S., Drane, D., Davis, R., Beezum, L., Pearse, M., and Cox, J. (2001) Intranasal immunisation with influenza-ISCOM induces strong mucosal as well as systemic antibody and cytotoxic T-lymphocyte responses. Vaccine. vol. 19(28-29) 4072-80
136. Tourdot, S., Herath, S., and Gould, K. G. (2001) Characterization of a new H-2D(k)-restricted epitope prominent in primary influenza A virus infection. Journal of General Virology. vol. 82 1749-55
137. Tsurita, M., Kurokawa, M., Imakita, M., Fukuda, Y., Watanabe, Y., and Shiraki, K. (2001) Early augmentation of interleukin (IL)-12 level in the airway of mice administered orally with clarithromycin or intranasally with IL-12 results in alleviation of influenza infection. Journal of Pharmacology and Experimental Therapeutics. vol. 298(1) 362-8
138. Vignuzzi, M., Gerbaud, S., Van Der Werf, S., and Escriou, N. (2001) Naked RNA immunization with replicons derived from poliovirus and Semliki Forest virus genomes for the generation of a cytotoxic T cell response against the influenza A virus nucleoprotein. Journal of General Virology. vol. 82 1737-47
139. Wang, X., Castro, A. E., Castro, M. D., Lu, H., Weinstock, D., Soyster, N., Scheuchenzuber, W., and Perdue, M. (2000) Production and evaluation criteria of specific monoclonal antibodies to the hemagglutinin of the H7N2 subtype of avian influenza virus. Journal of Veterinary Diagnostic Investigation. vol. 12(6) 503-9
140. Wu, B., Wu, J. M., Miagkov, A., Adams, R. N., Levitsky, H. I., and Drachman, D. B. (2001) Specific immunotherapy by genetically engineered APCs: the "guided missile" strategy. Journal of Immunology. vol. 166(7) 4773-79
Structure, function and genetics
141. Aronsson, F., Karlsson, H., Ljunggren, H. G., and Kristensson, K. (2001) Persistence of the influenza A/WSN/33 virus RNA at midbrain levels of immunodefective mice. Journal of Neurovirology. vol. 7(2) 117-24
142. Barman, S., Ali, A., Hui, E. K. W., Adhikary, L., and Nayak, D. P. (2001) Transport of viral proteins to the apical membranes and interaction of matrix protein with glycoproteins in the assembly of influenza viruses. Virus Research. vol. 77(1) 61-9
143. Bianco, A., Brufani, M., Manna, F., and Melchioni, C. (2001) Synthesis of a carbocyclic sialic acid analogue for the inhibition of influenza virus neuraminidase. Carbohydrate Research. vol. 332(1) 305-09
144. Bianco, A., Brufani, M., and Melchioni, C. (2001) Aromatic sialic acid analogues as potential inhibitors of influenza virus neuraminidase. Farmaco . vol. 56(4) 305-9
145. Conti, G., Portincasa, P., Visalli, S., and Chezzi, C. (2001) Inhibition by prostaglandin PGA1 on the multiplication of influenza virus is a dose-dependent effect. Virus Research. vol. 75(1) 43-57
146. Cullen, B. R. (2001) Journey to the center of the cell. [Review] [20 refs]. Cell. vol. 105(6) 697-700
147. Edwards, M. J. and Dimmock, N. J. (2001) A haemagglutinin (HA1)-specific FAb neutralizes influenza A virus by inhibiting fusion activity. Journal of General Virology. vol. 82(Pt 6) 1387-95
148. Epand, R. F., Yip, C. M., Chernomordik, L. V., Leduc, D. L., Shin, Y. K., and Epand, R. M. (2001) Self-assembly of influenza hemagglutinin: studies of ectodomain aggregation by in situ atomic force microscopy. Biochimica Et Biophysica Acta-Biomembranes. vol. 1513(2) 167-75
149. Epand, R. M., Epand, R. F., Martin, I., and Ruysschaert, J. M. (2001) Membrane interactions of mutated forms of the influenza fusion peptide. Biochemistry. vol. 40(30) 8800-7
150. Govorkova, E. A. and Smirnov, I. A. (2000) [Molecular basis and mechanisms of Influenza viruses adaptation to reproduction in murine lung]. [Review] [69 refs] [Russian]. Voprosy Virusologii. vol. 45(5) 4-10
151. Han, X., Bushweller, J. H., Cafiso, D. S., and Tamm, L. K. (2001) Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin. Nature Structural Biology. vol. 8(8) 715-20
152. Hardy, I., Li, Y., Coulthart, M. B., Goyette, N., and Boivin, G. (2001) Molecular evolution of influenza A/H3N2 viruses in the province of Quebec (Canada) during the 1997-2000 period. Virus Research. vol. 77(1) 89-96
153. Hooker, L., Strong, R., Adams, R., Handa, B., Merrett, J. H., Martin, J. A., and Klumpp, K. (2001) A sensitive, single-tube assay to measure the enzymatic activities of influenza RNA polymerase and other poly(A) polymerases: application to kinetic and inhibitor analysis. Nucleic Acids Research. vol. 29(13) 2691-8
154. Kai, H., Matsumoto, H., Hattori, N., Takase, A., Fujiwara, T., and Sugimoto, H. (2001) Anti-influenza virus activities of 2-alkoxyimino-N-(2-isoxazolin-3-ylmethyl)acetamides. Bioorganic & Medicinal Chemistry Letters. vol. 11(15) 1997-2000
155. Keren, T., Roth, I. G., and Henis, Y. I. (2001) Internalization-competent influenza hemagglutinin mutants form complexes with clathrin-deficient multivalent AP-2 oligomers in live cells. Journal of Biological Chemistry. vol. 276(30) 28356-63
156. Krossoy, B., Nilsen, F., Falk, K., Endresen, C., and Nylund, A. (2001) Phylogenetic analysis of infectious salmon anaemia virus isolates from Norway, Canada and Scotland. Diseases of Aquatic Organisms. vol. 44(1) 1-6
157. Latham, T. and Galarza, J. M. (2001) Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. Journal of Virology. vol. 75(13) 6154-65
158. Leahy, M. B., Dobbyn, H. C., and Brownlee, G. G. (2001) Hairpin loop structure in the 3 ' arm of the influenza A virus virion RNA promoter is required for endonuclease activity. Journal of Virology. vol. 75(15) 7042-49
159. Leikina, E., Leduc, D. L., Macosko, J. C., Epand, R., Epand, R., Shin, Y. K., and Chernomordik, L. V. (2001) The 1-127 HA2 construct of influenza virus hemagglutinin induces cell-cell hemifusion. Biochemistry. vol. 40(28) 8378-86
160. Ludwig, S., Ehrhardt, C., Neumeier, E. R., Kracht, M., Rapp, U. R., and Pleschka, S. (2001) Influenza virus-induced AP-1-dependent gene expression requires activation of the JNK signaling pathway. Journal of Biological Chemistry. vol. 276(24) 10990-98
161. Luschow, D., Werner, O., Mettenleiter, T. C., and Fuchs, W. (2001) Protection of chickens from lethal avian influenza A virus infection by live-virus vaccination with infectious laryngotracheitis virus recombinants expressing the hemagglutinin (H5) gene. Vaccine. vol. 19(30) 4249-59
162. McKay, D. (2001) Influenza virus replication blocked. Trends in Biotechnology. vol. 19(5) p. 163
163. Naffakh, N., Massin, P., and Van Der Werf, S. (2001) The transcription/replication activity of the polymerase of influenza A viruses is not correlated with the level of proteolysis induced by the PA subunit. Virology. vol. 285(2) 244-52
164. Nelson, H. K., Shi, Q., Van Dael, P., Schiffrin, E. J., Blum, S., Barclay, D., Levander, O. A., and Beck, M. A. (2001) Host nutritional selenium status as a driving force for influenza virus mutations. FASEB Journal. vol. 15(8) 1824-8
165. Okada, A., Miura, T., and Takeuchi, H. (2001) Protonation of histidine and histidine-tryptophan interaction in the activation of the M2 ion channel from influenza A virus. Biochemistry . vol. 40(20) 6053-60
166. Paragas, J., Talon, J., O'neill, R. E., Anderson, D. K., Garcia-Sastre, A., and Palese, P. (2001) Influenza B and C virus NEP (NS2) proteins possess nuclear export activities. Journal of Virology. vol. 75(16) 7375-83
167. Perez, D. R. and Donis, R. O. (2001) Functional analysis of PA binding by influenza a virus PB1: Effects on polymerase activity and viral infectivity. Journal of Virology. vol. 75(17) 8127-36
168. Prokudina, E. N., Semenova, N. P., Chumakov, V. M., Rudneva, I. A., and Yamnikova, S. S. (2001) Extracellular truncated influenza virus nucleoprotein. Virus Research. vol. 77(1) 43-9
169. Puertollano, R., Martinez-Menarguez, J. A., Batista, A., Ballesta, J., and Alonso, M. A. (2001) An intact dilysine-like motif in the carboxyl terminus of MAL is required for normal apical transport of the influenza virus hemagglutinin cargo protein in epithelial Madin-Darby canine kidney cells. Molecular Biology of the Cell. vol. 12(6) 1869-83
170. Rimmelzwaan, G. F., Kuiken, T., Van Amerongen, G., Bestebroer, T. M., Fouchier, R. A. M., and Osterhaus Adme (2001) Pathogenesis of influenza A (H5N1) virus infection in a primate model. Journal of Virology. vol. 75(14) 6687-91
171. Rimstad, E., Mjaaland, S., Snow, M., Mikalsen, A. B., and Cunningham, C. O. (2001) Characterization of the infectious salmon anemia virus genomic segment that encodes the putative hemagglutinin. Journal of Virology. vol. 75(11) 5352-6
172. Rudneva, I. A., Gambarian, A. S., Shilov, A. A., Sinitsyn, B. V., Kropotkina, E. A., Il'iushina, N. A., and Kaverin, N. V. (2001) [Reduction of the functional match of influenza virus hemagglutinin and neuraminidase after reassortation of genes]. [Russian]. Molekuliarnaia Biologiia . vol. 35(3) 500-3
173. Rudneva, I. A., Gambaryan, A. S., Shilov, A. A., Sinitsyn, B. V., Kropotkina, E. A., Il'yushina, N. A., and Kaverin, N. V. (2001) Functional match between influenza virus hemagglutinin and neuraminidase is restored after gene reassortment. Molecular Biology. vol. 35(3) 423-25
174. Schultz-Cherry, S., Dybdahl-Sissoko, N., Neumann, G., Kawaoka, Y., and Hinshaw, V. S. (2001) Influenza virus NS1 protein induces apoptosis in cultured cells. Journal of Virology. vol. 75(17) 7875-81
175. Singh, S. B. and Tomassini, J. E. (2001) Synthesis of natural flutimide and analogous fully substituted pyrazine-2,6-diones, endonuclease inhibitors of influenza virus. Journal of Organic Chemistry. vol. 66(16) 5504-16
176. Stamatiou, G., Kolocouris, A., Kolocouris, N., Fytas, G., Foscolos, G. B., Neyts, J., and De Clercq, E. (2001) Novel 3-(2-adamantyl)pyrrolidines with potent activity against influenza A virus - Identification of aminoadamantane derivatives bearing two pharmacophoric amine groups. Bioorganic & Medicinal Chemistry Letters. vol. 11(16) 2137-2142
177. Stray, S. J. and Air, G. M. (2001) Apoptosis by influenza viruses correlates with efficiency of viral mRNA synthesis. Virus Research. vol. 77(1) 3-17
178. Sugahara, K., Hongo, S., Sugawara, K., Li, Z. N., Tsuchiya, E., Muraki, Y., Matsuzaki, Y., and Nakamura, K. (2001) Role of individual oligosaccharide chains in antigenic properties, intracellular transport, and biological activities of influenza C virus hemagglutinin-esterase protein. Virology. vol. 285(1) 153-64
179. Tchatalbachev, S., Flick, R., and Hobom, G. (2001) The packaging signal of influenza viral RNA molecules. Rna-a Publication of the Rna Society. vol. 7(7) 979-89
180. Thacker, E. L., Thacker, B. J., and Janke, B. H. (2001) Interaction between Mycoplasma hyopneumoniae and swine influenza virus. Journal of Clinical Microbiology. vol. 39(7) 2525-30
181. Timofeeva, T. A., Klenk, H. D., and Zhirnov, O. P. (2001) Identification of the protease-binding domain in the N-terminal region of influenza virus A matrix protein M1. Molecular Biology. vol. 35(3) 484-91
182. Watanabe, K., Takizawa, N., Katoh, M., Hoshida, K., Kobayashi, N., and Nagata, K. (2001) Inhibition of nuclear export of ribonucleoprotein complexes of influenza virus by leptomycin B. Virus Research. vol. 77(1) 31-42
183. Watanabe, T., Watanabe, S., Ito, H., Kida, H., and Kawaoka, Y. (2001) Influenza A virus can undergo multiple cycles of replication without M2 ion channel activity. Journal of Virology. vol. 75(12) 5656-62
184. Zhelev, D. V., Stoicheva, N., Scherrer, P., and Needham, D. (2001) Interaction of synthetic HA2 influenza fusion peptide analog with model membranes. Biophysical Journal. vol. 81(1) 285-304